mitomycin has been researched along with uracil in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (32.87) | 18.7374 |
| 1990's | 60 (41.96) | 18.2507 |
| 2000's | 27 (18.88) | 29.6817 |
| 2010's | 7 (4.90) | 24.3611 |
| 2020's | 2 (1.40) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fujita, K; Igawa, M; Kakehi, Y; Konami, T; Nishio, Y; Takenaka, I; Tomoyoshi, T; Usui, T; Yoshida, O | 1 |
| Fushida, S; Kaji, M; Kosaka, T; Matsumoto, H; Muraoka, K; Nakai, M; Segawa, M; Takano, Y; Tsugawa, K; Yonemura, Y | 1 |
| Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K | 1 |
| Akagi, M; Kakegawa, T; Maehara, Y; Shimazu, H; Sugimachi, K; Tomita, M | 1 |
| Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J | 1 |
| Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K | 1 |
| Fujii, S; Iwamoto, S; Kotake, H; Mashiba, H; Murai, N; Okuno, F; Sawada, Y; Yurino, N | 1 |
| Aoyama, H; Chiba, Y; Fukushi, G; Fukushi, M; Kimura, M; Matsukawa, M; Sakata, Y; Sato, T; Sawada, Y; Wada, K | 1 |
| Eida, K; Hirano, T; Ishii, T; Ishikawa, H; Kotake, Y; Kusano, H; Nakagoe, T; Shimizu, T; Shimoyama, T; Tomita, M | 1 |
| Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Taira, A; Yamamoto, H; Yamanouchi, A | 1 |
| Fujimura, T; Fushida, S; Kamata, T; Matuki, N; Matumoto, H; Sawa, T; Takegawa, S; Tsugawa, K; Urade, M; Yonemura, Y | 1 |
| Furukawa, H; Hara, T; Taniguchi, T | 1 |
| Ito, T; Izumi, T; Kiyohashi, A; Kurihara, M; Ohkubo, T; Sasai, T; Suga, S; Takahashi, H; Yaosaka, T; Yoshida, S | 1 |
| Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K | 1 |
| Gotoda, H; Kinami, Y; Miyazaki, I; Saito, H; Takashima, S; Tomita, F; Yamaguchi, A | 1 |
| Eida, K; Hirano, T; Ishii, T; Ishikawa, H; Kotake, Y; Nakagoe, T; Nogawa, T; Shimizu, T; Tobinaga, K; Tomita, M | 1 |
| Anada, E; Fujimura, T; Fujita, H; Haryo, S; Sawasaki, K; Shima, Y; Shiota, S | 1 |
| Kato, M; Kinoshita, K; Miwa, K; Ohyama, S; Sawa, T; Segawa, M; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Fujita, M; Fujita, Y; Ota, J; Sakamoto, Y; Sugimoto, T; Taguchi, T | 1 |
| Houjo, K; Kawano, N; Moriya, Y; Sugihara, K | 1 |
| Baba, H; Kakeji, Y; Kohnoe, S; Maehara, Y; Sugimachi, K; Watanabe, A | 1 |
| Anai, H; Korenaga, D; Maehara, Y; Ohi, Y; Okada, Y; Okubo, K; Sugimachi, K | 1 |
| Asakura, T; Fukuda, M; Imaki, S; Kanasugi, K; Komoriyama, H; Morikubo, M; Okamura, R; Tsukikawa, S; Watanabe, H; Yamaguchi, S | 1 |
| Fujimura, T; Hasegawa, K; Kato, M; Kinoshita, K; Miyata, T; Ohyama, S; Sawa, T; Takekawa, S; Ueda, N; Watanabe, T | 1 |
| Hisamatsu, K; Ihara, T; Kirimoto, K; Matsuda, M; Nanba, K; Okamoto, E; Suemitsu, H; Yamada, M | 1 |
| Chiba, T; Hiura, M; Kaneko, H; Kawamurra, S; Moriwaki, S; Tanaka, M; Yokoyama, T | 1 |
| Aoki, Y; Asae, M; Ichimiya, G; Imai, T; Kakihara, M; Kashitani, M; Katsumi, M; Ooshima, K; Tabuse, Y; Tanimura, H | 1 |
| Fukada, H; Itoh, Y; Kageyama, T; Mori, H; Ohyabu, H; Sugimori, K; Tsuji, M | 1 |
| Asaki, S; Goto, Y; Kikuchi, T; Koizumi, M; Mochizuki, F; Nomura, N; Ohkubo, T; Satoh, J; Taima, T; Toyota, T | 1 |
| Hozumi, T; Imamura, Y; Irie, K; Katou, J; Matsushita, K; Okutani, T; Oya, M; Yasutake, K; Yoshimura, Y | 1 |
| Hirosawa, H; Katayama, K; Matsuki, N; Sakuma, H; Sawa, T; Takano, N; Tanaka, T; Tomita, F; Ueno, K; Uogishi, M | 1 |
| Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Komi, N; Kondo, T; Kunitomo, K; Ogawa, N; Taguchi, T; Uchino, J | 1 |
| Hayashi, S; Kamejima, N; Kasugai, T; Kataoka, M; Kureyama, Y; Masaoka, A; Mitsui, T; Taniwaki, S; Tsuji, H; Watarai, N | 1 |
| Arakawa, H; Furuya, M; Inoue, Y; Koizumi, R; Masamune, O; Mukojima, T; Nakamura, J; Nasu, H; Ookubo, M; Yamada, N | 1 |
| Jin, ML | 1 |
| Aramaki, K; Hayashi, T; Johsen, T; Matsuura, H; Nasu, Y | 1 |
| Ito, T; Izumi, T; Kurihara, M; Sasaki, J | 1 |
| Goto, S; Horiuchi, Y; Nagayo, T; Ohkita, T; Shimaji, T; Suga, S; Yokoyama, Y | 1 |
| Fujita, F; Fujita, M; Hirai, T; Taguchi, T | 1 |
| Matsuki, N; Miyata, R; Miyazaka, I; Noto, H; Ogino, S; Ohyama, S; Sakuma, H; Sawa, T; Yagi, M; Yonemura, Y | 1 |
| Horiuchi, Y; Ina, K; Suga, S | 1 |
| Matsuo, SK; Ohmura, K; Ohtsuka, Y; Suzuki, M | 1 |
| Adachi, M; Sasaki, M | 1 |
| Kikuchi, R; Mai, M; Takahashi, Y; Ueno, M | 1 |
| Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nishigaki, H; Okuda, T; Taniwaki, M; Tsuji, H; Yashige, H; Yokota, S | 1 |
| Ina, K; Iwase, H; Masuda, T; Morise, K; Ohashi, M; Suga, S | 1 |
| Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Simura, H; Yamamoto, H; Yamanouchi, A | 1 |
| Hirakawa, K; Ioka, J; Ishibashi, H; Kitagawa, Y; Nakajima, H; Ochiai, K; Shirono, K; Tanabe, S; Tomita, K | 1 |
| Fujimura, T; Fushida, S; Hisazumi, H; Kamata, T; Miwa, K; Miyazaki, I; Nakajima, K; Takegawa, S; Urade, M; Yonemura, Y | 1 |
| Kisu, T; Mori, H; Muto, Y; Uchida, Y; Yamaoka, K | 1 |
| Fukuyama, E; Kamano, T; Kubo, Y; Kurihara, M; Miyoshi, K; Nakano, S; Oda, K; Sasai, T; Suwa, T; Taguchi, S | 1 |
| Hagino, S; Katayama, K; Matsuki, N; Note, M; Sakuma, H; Sawa, T; Sawazaki, K; Ueno, K; Uogishi, M; Yagi, M | 1 |
| Abe, T; Horiike, S; Misawa, S; Nishigaki, H; Takeda, S; Takino, T; Taniwaki, M; Tsuda, S; Tsuji, T; Yashige, H | 1 |
| Arai, Y; Endo, T; Kido, C; Miyake, Y; Ozawa, H; Sato, Y | 1 |
| Baba, T; Furukohori, N; Itoh, T; Kawata, K; Kimura, T; Munakata, A; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y | 1 |
| Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K | 1 |
| Mai, M; Ohta, T; Takahashi, Y | 1 |
| Furusawa, M; Inokuchi, K; Matsusaka, T; Noda, S; Oka, N; Okamura, T; Saku, M; Sugimachi, K; Teraoka, H; Toda, T | 1 |
| Hatano, T; Hayakawa, M; Igarashi, M; Kashiwabara, N; Koyama, Y; Miyazato, T; Osawa, A; Saito, S; Sato, K | 1 |
| Ina, K; Iwase, H; Matsuoka, S; Matsuura, T; Morise, K; Nomoto, K; Suga, S; Takeda, N | 1 |
| Arai, Y; Endo, T; Kido, C; Ota, K; Suyama, K | 1 |
| Hashimoto, T; Kamata, T; Katayama, K; Miyata, R; Miyazaki, I; Nakajima, K; Saito, Y; Sawa, T; Takegawa, S; Yonemura, Y | 1 |
| Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M | 1 |
| Hashizume, H; Horiuchi, T; Ina, K; Iwase, H; Kimura, K; Matsuoka, S; Matsuura, T; Suga, S; Takada, N; Yamada, K | 1 |
| Kimura, K; Suga, S; Yokoyama, Y | 2 |
| Izumi, T; Kurihara, M; Maruyama, T; Sasaki, Y; Shirakabe, H | 1 |
| Demachi, H; Konishi, K; Kuroda, Y; Tsugawa, K; Tsuji, M; Yabushita, K | 1 |
| Furukawa, H; Goto, S; Hiratsuka, M; Iwanaga, T; Kito, T; Nakajima, T; Nakazato, H; Ohta, K; Okabayashi, K; Yamamura, Y | 1 |
| Ikuta, H; Shibagaki, F; Tsuji, Y | 1 |
| Higaki, T; Ito, Y; Kono, S; Moriguchi, M; Nakata, Y; Oishi, H; Seki, N; Takahashi, T; Takano, S; Watanabe, Y | 1 |
| Wakui, A | 1 |
| Baba, H; Furusawa, M; Kakeji, Y; Maehara, Y; Okuyama, T; Sugimachi, K | 1 |
| Endo, T; Hatakeyama, S; Ho, N; Katagiri, J; Onuki, K; Sasagawa, T; Sekine, T; Sugiyama, K; Togashi, M; Tomidokoro, T | 1 |
| Aoki, T; Ashikaga, K; Hirai, K; Kawahara, H; Kimura, C; Kuroda, H; Ono, M; Sato, K; Yamada, Y | 1 |
| Arima, S; Hisatsugu, T; Ohsato, K; Shimura, H | 1 |
| Honma, H; Kang, K; Tozawa, K; Washida, H; Yamada, Y | 1 |
| Fukuyama, Y; Hasegawa, K; Hayakawa, M; Ishikawa, K; Iwazaki, R; Koizumi, W; Kubo, Y; Kurihara, M; Sasai, T; Yasutake, K | 1 |
| Itsubo, M | 1 |
| Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Komi, N; Kondo, T; Maehara, Y; Sugimachi, K; Taguchi, T; Uchino, J | 1 |
| Azuma, S; Furuta, T; Kato, M; Kuno, T; Nishina, T; Saji, S; Takahashi, K; Tanemura, H | 1 |
| Kiyohashi, A; Kurihara, M; Ohkubo, T; Suga, S; Yoshida, S | 1 |
| Sakakibara, N; Watanabe, H | 1 |
| Kato, M; Kinoshita, K; Matsui, H; Miyazaki, I; Sawa, T; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Fugimura, T; Fushida, S; Kanno, M; Michiwa, Y; Miwa, K; Miyazaki, I; Nishimura, G; Sato, T; Sugiyama, K; Yagi, H; Yamaguchi, A; Yonemura, Y | 1 |
| Honma, A; Ishikawa, N; Ishikawa, T; Kamimura, T; Oota, H; Ozaki, T; Takeda, K; Yoshida, T | 1 |
| Fujioka, A; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Ikeda, E; Isomoto, H; Kato, T; Kodaira, S; Okuda, M; Takahashi, T; Teramoto, T; Yamamoto, Y | 1 |
| Fujii, M | 1 |
| Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S | 1 |
| Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y | 1 |
| Aiura, K; Arisawa, Y; Ishii, S; Kakefuda, T; Kitagawa, Y; Kogure, A; Nakagawa, M; Noga, K; Shirasugi, N | 1 |
| Kakegawa, T; Maehara, Y; Ogawa, M; Sugimachi, K; Tomita, M | 1 |
| Inaji, H; Koyama, H; Motomura, K; Noguchi, S | 1 |
| Hata, K; Kaganoi, J; Nanbu, H; Nishitai, R; Ohsumi, K; Tokunaga, Y | 1 |
| Baba, H; Kakeji, Y; Maehara, Y; Ohno, S; Sugimachi, K | 1 |
| Kodaira, S | 1 |
| Danjo, Y; Takayanagi, N | 1 |
| Abe, O; Demura, H; Endo, M; Kawamura, E; Kimura, K; Kubota, T; Nakao, I; Saito, T; Sasano, H; Sasano, N | 1 |
| Aiba, K; Azekura, K; Kokudo, N; Matsubara, T; Moroguchi, A; Nakajima, T; Ohta, H; Sato, T; Seki, M; Takahashi, T; Ueno, M | 1 |
| Kaminishi, M; Shimizu, N; Shimoyama, S | 1 |
| Ichikawa, A; Inada, T; Kawakubo, H; Ogata, Y | 1 |
| Hitomi, S; Miyahara, R; Tanaka, F; Wada, H | 1 |
| Ajisaka, H; Bando, E; Fujimura, T; Fushida, S; Hayashi, T; Minatoya, T; Miwa, K; Nishimura, G; Taniguchi, K; Yonemura, Y | 1 |
| Ajani, JA; Yao, JC | 1 |
| Baba, H; Kikunaga, H; Matsudo, A; Miura, H; Morisue, A; Nakai, H; Osakabe, Y; Sotome, K; Takao, M | 1 |
| Katayama, A; Mafune, K; Makuuchi, M | 1 |
| Jakobsen, A | 1 |
| Kodaira, S; Nozawa, K; Shatari, T | 1 |
| Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H | 1 |
| Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R | 1 |
| Danno, M; Ishibiki, K; Kumashiro, R; Kunii, Y; Kunitomo, K; Sakamoto, Y; Shiroto, H; Tamura, Y; Yamamura, Y | 1 |
| Aoyagi, S; Hisamatsu, T; Ikezawa, T; Matsuoka, K; Mizuno, Y; Motohashi, Y; Nishida, J; Tatsuno, S | 1 |
| Earashi, M; Kobayashi, H; Matsuki, N; Michiwa, Y | 1 |
| Akamo, Y; Hasegawa, M; Manabe, T; Takeyama, H; Teranishi, F | 1 |
| Ito, T; Nakamura, A; Sato, A; Taguchi, S; Tomita, T | 1 |
| Boku, N; Fukuda, H; Hyodo, I; Ikeda, N; Miyata, Y; Ohtsu, A; Saito, H; Shimada, Y; Shirao, K; Yamamichi, N; Yamamoto, S; Yoshida, S | 1 |
| Kakeji, Y; Kohnoe, S; Maehara, Y | 1 |
| Miyazaki, M; Nakamori, Y; Shinohara, K; Taguchi, A; Tominaga, T | 1 |
| BEERMANN, W; CLEVER, U | 1 |
| MELECHEN, NE; SENO, T | 1 |
| BRINKLEY, BR; FRAMPTON, EW | 1 |
| DAVISON, CL; PAPIRMEISTER, B | 1 |
| Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T | 1 |
| Hojyo, K; Isomoto, H; Kato, T; Kodaira, S; Kunii, Y; Kunitomo, K; Niimoto, M; Nishida, O; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
| Frödin, JE; Glimelius, B; Gyldenkerne, N; Hansen, F; Jakobsen, A; Keldsen, N; Kjaer, M; Pfeiffer, P; Sandberg, E | 1 |
| Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M | 1 |
| Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Izumiyama, K; Koshino, T; Sakita, I; Soma, I; Yoshida, T | 1 |
| Ichinose, Y; Okamoto, T | 1 |
| Amano, T; Hiki, Y; Kumada, K; Mitomi, T; Nishiyama, K; Noto, T; Ogawa, N; Oka, H; Oki, S; Otani, Y; Sadahiro, S; Takahashi, T; Takemiya, S; Tsuchiya, S; Yamakawa, T; Yamamura, T | 1 |
| Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
| Aikou, T; Haraguchi, Y; Ikeda, N; Kamikado, C; Sakamoto, F; Toyoyama, H; Ueno, S | 1 |
| Maeda, Y; Sasaki, E; Sasaki, T | 1 |
| Depisch, D; Föger, A; Gruhsmann, B; Kornek, GV; Lang, F; Lenauer, A; Scheithauer, W; Vormittag, L | 1 |
| Chung, YL; Jen, YM; Lin, YH; Wang, LW; Yen, SH | 1 |
| Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D | 1 |
| Ahn, MS; Cho, YK; Choi, JH; Han, SU; Jeong, SH; Kang, SY; Lee, HW; Lee, KJ; Lee, SY; Lim, HY; Park, JS | 1 |
| Chen, CC; Jiang, RS; Liang, KL; Lin, JC; Lin, PJ; Liu, YC; Shih, YT; Twu, CW; Wang, WY; Wu, CT | 1 |
| Alabiso, I; Alabiso, O; Baratelli, C; Brizzi, MP; Di Maio, M; Forti, L; Ottone, A; Scagliotti, GV; Sonetto, C; Tampellini, M | 1 |
| Baba, H; Beppu, T; Chikamoto, A; Fukubayashi, K; Hayashi, H; Imai, K; Imamura, YU; Ishiko, T; Miyata, T; Yamashita, YI | 1 |
| Chang, WH; Li, YT | 1 |
10 review(s) available for mitomycin and uracil
| Article | Year |
|---|---|
[Chemotherapy of scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levoleucovorin; Mitomycin; Nimustine; Recombinant Proteins; Stomach Neoplasms; Tegafur; Uracil | 1994 |
Intraarterial infusion chemotherapy for unresectable hepatic metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1996 |
[Benefits of adjuvant chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Mitomycin; Randomized Controlled Trials as Topic; Tamoxifen; Tegafur; Uracil | 1997 |
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Mitomycin; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Adrenalectomy for solitary adrenal metastasis from colorectal carcinoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Floxuridine; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Rectal Neoplasms; Tegafur; Uracil | 2000 |
[Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Mitomycin; Randomized Controlled Trials as Topic; Semustine; Survival Rate; Tegafur; Uracil; Vincristine | 2000 |
[Chemotherapy of gastric cancer--a review of clinical trials in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Combinations; Floxuridine; Humans; Japan; Methotrexate; Mitomycin; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 2002 |
[Progress in adjuvant therapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Mitomycin; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Uracil | 2002 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
47 trial(s) available for mitomycin and uracil
| Article | Year |
|---|---|
[Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cystectomy; Doxorubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Premedication; Tegafur; Uracil; Urinary Bladder Neoplasms | 1992 |
Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Picibanil; Prospective Studies; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1992 |
[Multihospital randomized study on pre- and post-operative adjuvant chemotherapy for colorectal cancer (Part 2)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Postoperative Care; Preoperative Care; Survival Rate; Tegafur; Uracil | 1991 |
[Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Humans; Lymphatic Metastasis; Mitomycin; Mitomycins; Postoperative Care; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1991 |
A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Postoperative Care; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1991 |
[Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Terminal Care; Uracil | 1990 |
[Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Picibanil; Remission Induction; Tegafur; Uracil | 1989 |
[Randomized-controlled study of treatment with UFT-MMC or UFT-ACR in advanced gastric cancer. Tohoku Study Group of Cancer Treatment for the Digestive Organs].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Random Allocation; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Japan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): 3-year survival after surgery of non-curatively resected patients. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Humans; Japan; Mitomycin; Mitomycins; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1989 |
[Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Random Allocation; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1989 |
[Combined UFTM for 140 patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mitomycin; Mitomycins; Postoperative Care; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Topic; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Prospective Studies; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1988 |
Randomized study with mitomycin C + 5-fluorouracil+cytosine arabinoside (MFC)+5-fluorouracil, MFC+tegafur and uracil (UFT), and MF+UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Japan; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1995 |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm, Residual; Portal Vein; Tegafur; Uracil | 1994 |
Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Gastrectomy; Humans; Injections, Intradermal; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Picibanil; Postoperative Care; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1994 |
[Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Mitomycin; Quality of Life; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1994 |
[The usefulness of pre- and immediately postoperative chemotherapy in colorectal cancer].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Mitomycin; Postoperative Care; Preoperative Care; Tegafur; Uracil | 1994 |
Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
[UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1993 |
[Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Cancer (fourth report): five-year results after surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Follow-Up Studies; Humans; Mitomycin; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1993 |
Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1993 |
[Evaluation of preoperative chemotherapy for colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Proliferating Cell Nuclear Antigen; Survival Rate; Tegafur; Uracil | 1996 |
[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Tegafur; Uracil | 1996 |
Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Proteoglycans; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1997 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for advanced colorectal carcinoma: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Mitomycin; Postoperative Period; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1997 |
Scientific basis for the combination of tegafur with uracil.
Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Intestinal Absorption; Male; Middle Aged; Mitomycin; Postoperative Care; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1997 |
Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Rectal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
Potential of the histoculture drug-response assay to contribute to cancer patient survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Tumor Stem Cell Assay; Uracil | 1995 |
Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Female; Gastrectomy; Humans; Intraoperative Care; Male; Middle Aged; Mitomycin; Postoperative Care; Prospective Studies; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1999 |
Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Postoperative Period; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vindesine | 1999 |
UFT/leucovorin combined with mitomycin-C in metastatic colorectal Ca.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Tegafur; Uracil | 2000 |
[Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Humans; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2001 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Japan; Male; Middle Aged; Mitomycin; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2003 |
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-flu
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Injections, Subcutaneous; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pyrimidines; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Tegafur; Treatment Outcome; Uracil | 2004 |
[Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Double-Blind Method; Eating; Female; Fluorouracil; Head and Neck Neoplasms; Histone Deacetylase Inhibitors; Humans; Male; Middle Aged; Mitomycin; Mouthwashes; Phenylbutyrates; Pilot Projects; Radiation Injuries; Radiotherapy Dosage; Stomatitis; Taiwan; Tegafur; Uracil; Weight Loss | 2012 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Colorectal Neoplasms; Drug Combinations; Drug Monitoring; Female; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Grading; Salvage Therapy; Survival Analysis; Tegafur; Tumor Burden; Uracil | 2012 |
5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Prevalence; Proteoglycans; Republic of Korea; Risk Factors; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2013 |
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Tegafur; Treatment Outcome; Uracil | 2018 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
87 other study(ies) available for mitomycin and uracil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Remission Induction; Reoperation; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neoplasms; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Mitomycin; Picibanil; Prognosis; Remission Induction; Rupture, Spontaneous; Tegafur; Uracil | 1991 |
[Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Gastrectomy; Humans; Hyperthermia, Induced; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Infusions, Parenteral; Injections, Intralesional; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Infusions, Parenteral; Injections, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[The usefulness of UFT administration in colorectal cancer with emphasis on postoperative administration (Part 3)].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplastic Cells, Circulating; Postoperative Period; Survival Rate; Tegafur; Uracil | 1991 |
[Prophylactic effect of allopurinol mouthwash against stomatitis induced by the chemotherapy (PMUE regimen) for gastrointestinal malignancies].
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Mitomycin; Mouthwashes; Stomatitis; Tegafur; Uracil | 1991 |
[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Preoperative Care; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[Evaluation of subselective intraarterial infusion chemotherapy in advanced gastric cancer and recurrence case-evaluated on factors other than direct effects].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Care; Tegafur; Uracil | 1990 |
Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Random Allocation; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1990 |
[A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[UFT-MT therapy in advanced or recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Remission Induction; Tamoxifen; Tegafur; Uracil | 1990 |
[Transformation of ovarian yolk sac tumor to immature teratoma following chemotherapy].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fluorouracil; Humans; Mesonephroma; Mitomycin; Mitomycins; Ovarian Neoplasms; Tegafur; Teratoma; Uracil | 1985 |
[Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report].
Topics: Amylases; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Necrosis; Ovarian Neoplasms; Ovariectomy; Ovary; Postoperative Period; Tegafur; Uracil | 1988 |
[An autopsy study of immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma in a patient previously treated with chemotherapy in colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Humans; Immunoblastic Lymphadenopathy; Lymphoma; Male; Mitomycin; Mitomycins; Neoplasms, Multiple Primary; T-Lymphocytes; Tegafur; Uracil | 1989 |
[Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Humans; Menopause; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Tegafur; Uracil; Vincristine | 1989 |
[An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Female; Gastrectomy; Humans; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[A case of peritoneal malignant mesothelioma with disappearance of ascites result of intraperitoneal instillation of mitomycin C and oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cryptorchidism; Humans; Infusions, Parenteral; Male; Mesothelioma; Mitomycin; Mitomycins; Peritoneal Neoplasms; Remission Induction; Tegafur; Testicular Hydrocele; Uracil | 1989 |
[Cancer chemotherapy of scirrhous type gastric cancer and evaluation of chemotherapeutic efficacy].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; Humans; Injections, Intravenous; Mitomycin; Mitomycins; Radiography; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Therapeutic treatment of Borrmann type 4 (scirrhous) gastric cancer-chemotherapy and histopathological studies].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Gastric Mucosa; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Evaluation by multiple regression analysis of factors influencing the chemosensitivity of human tumors xenografted into nude mice].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colony-Forming Units Assay; Doxorubicin; Floxuridine; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Regression Analysis; Tegafur; Tumor Stem Cell Assay; Uracil | 1987 |
[PMU therapy of recurrent gastric cancer. A case report].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Drug Administration Schedule; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Chemotherapy of Borrmann type 4 gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Drug Administration Schedule; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Penicillamine; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Retrospective Studies; Tegafur; Uracil | 1987 |
[A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Effect of combination of UFT and MMC (UFT-M therapy) on human colonic cancer xenotransplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colonic Neoplasms; Drug Administration Schedule; Humans; Male; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Tegafur; Uracil | 1987 |
[Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Lentinan; Male; Mitomycin; Mitomycins; Peritonitis; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Multimodal therapy using hyperthermia for gastric cancer--with special reference to histological studies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Hyperthermia, Induced; Mitomycin; Mitomycins; Models, Structural; Radiotherapy, High-Energy; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[UFTM therapy in patients with unresectable pancreatic cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Tegafur; Uracil | 1987 |
[Effect of PMU therapy (CDDP, MMC and UFT) against terminal gastric carcinoma. Hokuriku Cisplatin Round-table Conference].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Evaluation of a combination of UFT, MMC, and OK-432 for advanced gastro-intestinal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1987 |
[Changes in CT findings in patients with liver metastases of breast cancer during effective intra-arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Mastectomy; Mitomycin; Mitomycins; Postoperative Period; Tegafur; Tomography, X-Ray Computed; Uracil | 1988 |
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carbazilquinone; Drug Administration Schedule; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1988 |
[Effect of UFTM therapy on primary and metastatic colon cancer of human xenotransplanted in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Infusions, Parenteral; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Tegafur; Uracil | 1988 |
[Clinical studies of the treatment of bladder tumor and its effects--experience in 86 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Tegafur; Uracil; Urinary Bladder Neoplasms | 1988 |
[Morphologic evaluation of systemic chemotherapy for gastric cancer--using new criteria of the Research Society for Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabine; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Silicone Elastomers; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[A case of gastric cancer successfully treated with hyperthermo-chemo-radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hot Temperature; Humans; Lymphatic Metastasis; Middle Aged; Mitomycin; Mitomycins; Radiotherapy Dosage; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[UFT, UFTM, and UFTM-Dpc treatment of gastric cancer].
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia L1210; Male; Mice; Mitomycin; Mitomycins; Penicillamine; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1983 |
[UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Stomach Neoplasms; Tegafur; Uracil | 1984 |
[Chemotherapy of unresectable Borrmann type 4 gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1984 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gastrectomy; Humans; Infusions, Intravenous; Liver Neoplasms; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Tegafur; Uracil; Urinary Bladder Neoplasms | 1994 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Delivery Systems; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1993 |
[A case of secondary leukemia induced by chemotherapy with a CDDP-based regimen for gastric cancer 5 years following radical resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gastrectomy; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitomycin; Neoplasms, Second Primary; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Evaluation of long-term administration of oral anti-cancer agent].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Liver Neoplasms; Lymphatic Metastasis; Male; Mitomycin; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case of common bile duct cancer responding to MMC leucovorin, 5-FU, and UFT combination chemotherapy and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Common Bile Duct Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Mitomycin; Remission Induction; Tegafur; Uracil | 1996 |
[Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Colonic Neoplasms; Dinoprostone; Doxorubicin; Drug Combinations; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mitomycin; Survival Analysis; Tegafur; Tumor Cells, Cultured; Uracil | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseases; Diarrhea; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Mitomycin; Oxidoreductases; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1997 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Cisplatin; Drainage; Drug Combinations; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1998 |
Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Injections, Intravenous; Liver Neoplasms; Male; Medical Records; Middle Aged; Mitomycin; Multivariate Analysis; Retrospective Studies; Tegafur; Uracil | 1998 |
[Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Gastrectomy; Humans; Immunohistochemistry; Male; Middle Aged; Mitomycin; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Thymidine Phosphorylase; Tumor Suppressor Protein p53; Uracil | 1999 |
[A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Male; Mitomycin; Neoadjuvant Therapy; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Middle Aged; Mitomycin; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2000 |
[Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Fluorouracil; Hepatic Artery; Home Care Services; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2000 |
[Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Rectal Neoplasms; Reoperation; Tegafur; Uracil | 2001 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Etoposide; Female; Humans; Mitomycin; Skin Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2001 |
[Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Mitomycin; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 2001 |
Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Colonic Neoplasms; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Mitomycin; Neoplasms, Second Primary; Tegafur; Treatment Failure; Uracil | 2003 |
CHROMOSOME PUFFS.
Topics: Adenine; Animals; Autoradiography; Cell Division; Chloramphenicol; Chromosomal Puffs; Chromosomes; Dactinomycin; Diptera; DNA; Drosophila; Electrons; Electrophoresis; Guanine; Microscopy; Microscopy, Electron; Mitomycin; Mitomycins; Nucleic Acids; Photomicrography; Research; RNA; Uracil | 1964 |
MACROMOLECULAR SYNTHESES IN THE INITIATION OF BACTERIOPHAGE P1 INDUCTION.
Topics: Bacteriophage P1; Coliphages; DNA; DNA, Viral; Kinetics; Metabolism; Mitomycin; Mitomycins; Research; Ribosomes; RNA; RNA, Viral; Thymine; Uracil | 1964 |
EVIDENCE OF LYSOGENY IN DERIVATIVES OF ESCHERICHIA COLI.
Topics: Bacteriolysis; Carbon Isotopes; Coliphages; DNA, Bacterial; Electrons; Escherichia coli; Lysogeny; Metabolism; Microscopy; Microscopy, Electron; Mitomycin; Mitomycins; Nucleosides; Pharmacology; Radiation Effects; Radiometry; Research; RNA; RNA, Bacterial; Thymine; Ultraviolet Rays; Uracil; Uridine | 1965 |
UNBALANCED GROWTH AND LATENT KILLING OF ESCHERICHIA COLI FOLLOWING EXPOSURE TO SULFUR MUSTARD.
Topics: Culture Media; Deoxyribonucleases; DNA; DNA, Bacterial; Drug Resistance; Drug Resistance, Microbial; Escherichia coli; Metabolism; Mitomycin; Mitomycins; Mustard Compounds; Mustard Gas; Mutation; Research; RNA; RNA, Bacterial; Thymidine; Uracil | 1965 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Proteoglycans; Radiosurgery; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Etoposide; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined Modality Therapy; Drug Combinations; Duodenal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Palliative Care; Stents; Tegafur; Uracil | 2004 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[Comparison the standard therapies of gastric cancer in Japan with those in the West].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Europe; Fluorouracil; Gastrectomy; Humans; Japan; Lymph Node Excision; Mitomycin; Neoplasm Staging; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate; Tegafur; United States; Uracil | 2007 |
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease Progression; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Rectal Neoplasms; Retrospective Studies; Salvage Therapy; Tegafur; Uracil | 2007 |
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin; DNA, Viral; Drug Combinations; Epirubicin; Female; Fluorouracil; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Mitomycin; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2014 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Gamma Rays; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Tegafur; Uracil | 2019 |
The impact of adding mitomycin-C to radiotherapy plus oral tegafur-uracil on advanced-stage rectal cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Mitomycin; Rectal Neoplasms; Tegafur; Uracil | 2023 |